Pluripotent anti-inflammatory immunomodulatory effects of papaverine against cerebral ischemic-reperfusion injury

The mechanism of the papaverine (PV) for the treatment of cerebral ischemia remains unclear. A total of 42 mice induced with focal cerebral ischemia were randomly divided into three groups: PV,baicalin (BA)and vehicle group. Both PV and BA could significantly reduce the ischemic infarct volume (P &l...

Full description

Bibliographic Details
Main Authors: Shuang Guan, Qiong Liu, Hao Gu, Ying-ying Zhang, Peng-lu Wei, Yi-fei Qi, Jun Liu, Zhong Wang
Format: Article
Language:English
Published: Elsevier 2020-10-01
Series:Journal of Pharmacological Sciences
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1347861320300724
id doaj-b5b43c974fd3458cbef3178ace13bb64
record_format Article
spelling doaj-b5b43c974fd3458cbef3178ace13bb642020-11-25T04:00:52ZengElsevierJournal of Pharmacological Sciences1347-86132020-10-0114426975Pluripotent anti-inflammatory immunomodulatory effects of papaverine against cerebral ischemic-reperfusion injuryShuang Guan0Qiong Liu1Hao Gu2Ying-ying Zhang3Peng-lu Wei4Yi-fei Qi5Jun Liu6Zhong Wang7Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, ChinaInstitute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, ChinaInstitute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, ChinaGeriatric Department, Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine, Dongzhimen, Beijing 100007, ChinaInstitute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, ChinaInstitute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, ChinaInstitute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, China; Corresponding author.Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, China; Corresponding author.The mechanism of the papaverine (PV) for the treatment of cerebral ischemia remains unclear. A total of 42 mice induced with focal cerebral ischemia were randomly divided into three groups: PV,baicalin (BA)and vehicle group. Both PV and BA could significantly reduce the ischemic infarct volume (P < 0.05). Pathway enrichment analysis was performed on MetaCore™ to search the molecular pathways associated with the gene expression profile of PV, compared with vehicle and BA. Compared with vehicle, we found that 60% of the top 10 pathways in PV group were related to immune response. The top 10 biological processes of the targeted pathways were mainly related to the multiple immunomodulatory process of neuro-vascular inflammation, including immune_Th17-deried cytokins, regulation of angiogenesis, cell adhesion_Leucocyte chemotaxis, antigen presentation, cell adhesion_synaptic contact, and inflammation related to Amphoterin signaling. Moreover, compared with BA, 17 pathways of PV were identified, and 58.82% (10/17) were also related to immune response, especially, half of the top 10 pathways with the lower p-value. In these top 10 pathways, 4 were the cytokine-mediated signaling pathways, which play key role in inflammation, like IL-17 signaling pathways with the activation of G-CSF,IL-23,RANKL, p38MAPK and NF-κB.These findings indicate that PV may be an efficacious pluripotent anti-inflammatory agent against cerebral ischemic-reperfusion injury by targeting on multiple immunomodulatory process of neuro-vascular inflammation.http://www.sciencedirect.com/science/article/pii/S1347861320300724PapaverineCerebral ischemiaIschemic-reperfusionAnti-inflammationImmune response
collection DOAJ
language English
format Article
sources DOAJ
author Shuang Guan
Qiong Liu
Hao Gu
Ying-ying Zhang
Peng-lu Wei
Yi-fei Qi
Jun Liu
Zhong Wang
spellingShingle Shuang Guan
Qiong Liu
Hao Gu
Ying-ying Zhang
Peng-lu Wei
Yi-fei Qi
Jun Liu
Zhong Wang
Pluripotent anti-inflammatory immunomodulatory effects of papaverine against cerebral ischemic-reperfusion injury
Journal of Pharmacological Sciences
Papaverine
Cerebral ischemia
Ischemic-reperfusion
Anti-inflammation
Immune response
author_facet Shuang Guan
Qiong Liu
Hao Gu
Ying-ying Zhang
Peng-lu Wei
Yi-fei Qi
Jun Liu
Zhong Wang
author_sort Shuang Guan
title Pluripotent anti-inflammatory immunomodulatory effects of papaverine against cerebral ischemic-reperfusion injury
title_short Pluripotent anti-inflammatory immunomodulatory effects of papaverine against cerebral ischemic-reperfusion injury
title_full Pluripotent anti-inflammatory immunomodulatory effects of papaverine against cerebral ischemic-reperfusion injury
title_fullStr Pluripotent anti-inflammatory immunomodulatory effects of papaverine against cerebral ischemic-reperfusion injury
title_full_unstemmed Pluripotent anti-inflammatory immunomodulatory effects of papaverine against cerebral ischemic-reperfusion injury
title_sort pluripotent anti-inflammatory immunomodulatory effects of papaverine against cerebral ischemic-reperfusion injury
publisher Elsevier
series Journal of Pharmacological Sciences
issn 1347-8613
publishDate 2020-10-01
description The mechanism of the papaverine (PV) for the treatment of cerebral ischemia remains unclear. A total of 42 mice induced with focal cerebral ischemia were randomly divided into three groups: PV,baicalin (BA)and vehicle group. Both PV and BA could significantly reduce the ischemic infarct volume (P < 0.05). Pathway enrichment analysis was performed on MetaCore™ to search the molecular pathways associated with the gene expression profile of PV, compared with vehicle and BA. Compared with vehicle, we found that 60% of the top 10 pathways in PV group were related to immune response. The top 10 biological processes of the targeted pathways were mainly related to the multiple immunomodulatory process of neuro-vascular inflammation, including immune_Th17-deried cytokins, regulation of angiogenesis, cell adhesion_Leucocyte chemotaxis, antigen presentation, cell adhesion_synaptic contact, and inflammation related to Amphoterin signaling. Moreover, compared with BA, 17 pathways of PV were identified, and 58.82% (10/17) were also related to immune response, especially, half of the top 10 pathways with the lower p-value. In these top 10 pathways, 4 were the cytokine-mediated signaling pathways, which play key role in inflammation, like IL-17 signaling pathways with the activation of G-CSF,IL-23,RANKL, p38MAPK and NF-κB.These findings indicate that PV may be an efficacious pluripotent anti-inflammatory agent against cerebral ischemic-reperfusion injury by targeting on multiple immunomodulatory process of neuro-vascular inflammation.
topic Papaverine
Cerebral ischemia
Ischemic-reperfusion
Anti-inflammation
Immune response
url http://www.sciencedirect.com/science/article/pii/S1347861320300724
work_keys_str_mv AT shuangguan pluripotentantiinflammatoryimmunomodulatoryeffectsofpapaverineagainstcerebralischemicreperfusioninjury
AT qiongliu pluripotentantiinflammatoryimmunomodulatoryeffectsofpapaverineagainstcerebralischemicreperfusioninjury
AT haogu pluripotentantiinflammatoryimmunomodulatoryeffectsofpapaverineagainstcerebralischemicreperfusioninjury
AT yingyingzhang pluripotentantiinflammatoryimmunomodulatoryeffectsofpapaverineagainstcerebralischemicreperfusioninjury
AT pengluwei pluripotentantiinflammatoryimmunomodulatoryeffectsofpapaverineagainstcerebralischemicreperfusioninjury
AT yifeiqi pluripotentantiinflammatoryimmunomodulatoryeffectsofpapaverineagainstcerebralischemicreperfusioninjury
AT junliu pluripotentantiinflammatoryimmunomodulatoryeffectsofpapaverineagainstcerebralischemicreperfusioninjury
AT zhongwang pluripotentantiinflammatoryimmunomodulatoryeffectsofpapaverineagainstcerebralischemicreperfusioninjury
_version_ 1724448694312370176